铁质积聚药物恩瑞格哪里有？

(Deferasirox) is an iron chelator product developed by the Swiss pharmaceutical company Novartis. It is the first oral iron-removing agent approved by the U.S. FDA for routine use. It is approved for use in patients ≥2 years old with chronic iron overload caused by blood transfusion. In Europe, it is recommended as a first-line drug for patients with thalassemia iron overload over the age of 6. Today we will learn more about the iron accumulation drug Enriga. Where can I find it?

In 2010, Enrig (deferasirox) was approved for marketing in China. According to Medical Partner Travel, Enrig (deferasirox) has not been officially included in medical insurance. Enrig India Cipla Desirox 500mg*30 tablets is about 240$. Swiss Novartis Asunra 400mg*30 tablets is around 420$. Patients in need can purchase drugs abroad or obtain drugs through domestic professional overseas medical service organizations (such as Medical Companion Travel), which are guaranteed to be genuine.

It is recommended for patients with iron accumulation, such as those who require long-term blood transfusions (blood transfusions up to 100 ml/kg) and whose serum ferritin exceeds 1000 μg/L. According to the body weight, it is initially recommended to take a daily dose of 20 mg/kg of Enrig (deferasirox). Depending on the improvement of serum ferritin indicators, patients may need to adjust or increase the dose of Enrig. Generally, 5 mg/kg or 10 mg/ The dose is adjusted in units of kilograms, but the total dose should not exceed 30 mg/kg per day.

Deferasirox Dose Adjustments: Myelosuppression: Interrupt treatment; may restart once cause of cytopenias is determined; Contraindicated if platelet count <50,000/mm; Cutaneous Toxicity: Rash (severe): Interrupt treatment; may reintroduce at lower doses (with future dose escalations) and short-term oral corticosteroids. Serious skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme): Stop and evaluate. Gastrointestinal: Discontinue treatment for suspected gastrointestinal ulceration or bleeding. Hearing loss or visual impairment: Consider dose reduction or treatment interruption.

Enrig (deferasirox) is easy to administer, significantly reduces ferritin levels, and has a definite effect in protecting important target organ systems such as the liver, heart, and endocrine system. It is currently the preferred option for iron removal treatment.

The above is the content of the purchasing channels for (deferasirox), I hope it can help you!

Recommended related hot articles: /newsDetail/80961.html